Distribution Synergy A co-exclusive distribution partnership with Biocare Medical announced in March 2026 creates a ready-made channel to sell PreciPoint’s iO:M8 digital pathology solutions to labs already purchasing Biocare IHC/ISH reagents, enabling bundled digital imaging and intraoperative ROSE capabilities. Leverage joint marketing, demonstrations, and regional coverage to accelerate adoption among Biocare customers in EU and US markets.

OR Integration PreciPoint’s iO:M8 Digital Live Microscope supports intraoperative viewing of frozen sections, a high-value use case for surgical oncology centers. Target operating room workflows and pathology labs performing cancer surgeries, offering packages that pair the iO:M8 with ROSE-based intraoperative assessment to shorten turnaround times and improve intraoperative decision making. Propose pilots and live demos to drive trials.

Compliance Edge PreciPoint holds ISO 13485:2016 certification and CE‑IVD status, signaling regulatory readiness and supplier reliability attractive to hospitals expanding digital pathology in Europe and beyond. Use these credentials to differentiate in procurement conversations, providing documentation on quality management and post‑market support. Offer standardized procurement bundles with validated workflows and easy integration with existing image management systems.

Fluorescence Growth The company is pursuing a fluorescence platform integrated with the M8, creating an upgrade path to advanced multiplex imaging and broader pathology applications. Present cross-sell opportunities to current iO:M8 users and to new prospects in academic and research settings seeking fluorescence capabilities, with a roadmap for future feature additions and partner reagents/software alignment.

Agile Partner With a lean team and industry recognition as a Top Employer and Top100 Innovator, PreciPoint offers high-touch support and flexible deployment that can reduce time to value for regional hospitals and mid-size labs. Position as a nimble partner capable of tailored digital pathology workflows and quick onboarding, particularly in markets where local service and regulatory compliance matter.